Kura gets $45M milestone payment from Kyowa Kirin; Pliant’s restructuring
Plus, news about AstraZeneca, Otsuka and BioMarin: Kura Oncology records $45M milestone: It received the payment from Kyowa Kirin after the FDA submission of ziftomenib in April. The companies first ...
